Real-world experience with insulin glargine U300 in pediatric type 1 diabetes: glycemic control, insulin requirements, and patient-reported outcomes

Ilayda Altun, Didem Güneş Kaya, Mert Uçar, Yakup Gözderesi, Gökçe Velioğlu Haşlak, Hasan Karakaş, Elvan Bayramoğlu, Olcay Evliyaoglu, Hande Turan

Open source

DOI: 10.1186/s12902-026-02279-x
Published: 2026-04-17
Container: BMC Endocrine Disorders
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12902-026-02279-x,
  title = {Real-world experience with insulin glargine U300 in pediatric type 1 diabetes: glycemic control, insulin requirements, and patient-reported outcomes},
  author = {Ilayda Altun and Didem Güneş Kaya and Mert Uçar and Yakup Gözderesi and Gökçe Velioğlu Haşlak and Hasan Karakaş and Elvan Bayramoğlu and Olcay Evliyaoglu and Hande Turan},
  year = {2026},
  journal = {BMC Endocrine Disorders},
  doi = {10.1186/s12902-026-02279-x},
  url = {https://doi.org/10.1186/s12902-026-02279-x}
}

RIS

TY  - JOUR
TI  - Real-world experience with insulin glargine U300 in pediatric type 1 diabetes: glycemic control, insulin requirements, and patient-reported outcomes
AU  - Ilayda Altun
AU  - Didem Güneş Kaya
AU  - Mert Uçar
AU  - Yakup Gözderesi
AU  - Gökçe Velioğlu Haşlak
AU  - Hasan Karakaş
AU  - Elvan Bayramoğlu
AU  - Olcay Evliyaoglu
AU  - Hande Turan
PY  - 2026
JO  - BMC Endocrine Disorders
DO  - 10.1186/s12902-026-02279-x
UR  - https://doi.org/10.1186/s12902-026-02279-x
ER  -

APA

Altun, I., Kaya, D. G., Uçar, M., Gözderesi, Y., Haşlak, G. V., Karakaş, H., Bayramoğlu, E., Evliyaoglu, O., & Turan, H. (2026). Real-world experience with insulin glargine U300 in pediatric type 1 diabetes: glycemic control, insulin requirements, and patient-reported outcomes. BMC Endocrine Disorders. https://doi.org/10.1186/s12902-026-02279-x

Source records

crossref · retrieved 2026-11-10T12:39:17.114Z